Aminoglutethimide
（重定向自Cytadren）
![](/Images/godic/202501/07/Aminoglutethimide.svg1129.png")
Aminoglutethimide is an anti-steroid drug marketed under the tradename Cytadren by Novartis around the world. It blocks the production of steroids derived from cholesterol and is clinically used in the treatment of Cushing's syndrome and metastatic breast cancer. It is also used by body builders.